ArticleAddictive behaviors reports2018
Psychometric evaluation of a lifetime version of the marijuana problems scale.
Article in Addictive behaviors reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis.JAMA network open · 2020Pooled it
- Correlates of Engagement and Associations With Outcomes in a Cannabis Harm-Reduction Mobile App for Youth With First-Episode Psychosis: Exploratory Analysis of the CHAMPS Pilot Randomized Controlled Trial.JMIR formative research · 2026Trial
- Development and Validation of the Positive Outcomes of Cannabis Use Scale (POCUS) Among Predominantly White Adults in the United States.Assessment · 2025Article
- Associations between hair-derived cannabinoid levels, self-reported use, and cannabis-related problems.Psychopharmacology · 2024Article
- Examining substitution behaviors in a non-treatment sample of current drinkers: an exploratory study.Journal of social work practice in the addictions · 2024Article
- Evaluation of a Cannabis Harm Reduction Intervention for People With First-Episode Psychosis: Protocol for a Pilot Multicentric Randomized Trial.JMIR research protocols · 2023Article
- Prospective Associations Between Anxiety Sensitivity, Distress Intolerance, Depressive Symptoms, and Indices of Alcohol and Cannabis Use Among Veterans.Journal of studies on alcohol and drugs · 2023Article
- Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC).JMIR research protocols · 2022Article
- Promoting self-change in cannabis use disorder: Findings from a randomized trial.Frontiers in psychiatry · 2022Article
- Emotion Dysregulation Moderates the Association Between Stress and Problematic Cannabis Use.Frontiers in psychiatry · 2020Article
- Perceived Social Support from Significant Others among Binge Drinking and Polyconsuming Spanish University Students.International journal of environmental research and public health · 2019Article
- Insights from individuals successfully recovered from cannabis use disorder: natural versus treatment-assisted recoveries and abstinent versus moderation outcomes.Addiction science & clinical practice · 2018Article
- The Role of Savoring in Young Adult Cannabis Use and Associated Consequences: A Replication Study.Journal of psychoactive drugsArticle
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe Marijuana Problems Scale (MPS) is a widely-used self-report measure of cannabis-related negative consequences that has a past three-month reporting window. This report describes the psychometric characteristics of a lifetime version (MPS-L).
methodsAs part of a larger study, 119 individuals who had recovered from cannabis use disorder completed the MPS-L on two occasions 2 weeks apart and 91 participant-nominated family and friends also completed a collateral version of the scale.
resultsItem analyses and principal component analysis (PCA) revealed that three of the 19 items were relatively weaker. Omitting these items, the MPS-L showed good internal reliability (α = 0.88, for summed severity total, α = 0.85 for number of consequences identified) and test-retest reliability (
conclusionsThese analyses provide good preliminary support for a lifetime version of the MPS, with the summed severity total score performing slightly better than the total number of consequences endorsed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.